GMED
Globus Medical IncCompany with tickers: GMED
CIK
1237831
CUSIP
379577208
Shares Outstanding
113,314,529
13F Activity (30d)
432 filings
421 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $759,854,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $36,510,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $150,388,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $124,302,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.92 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.90 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |